Xinhua News reported that China’s National Center for Cardiovascular Diseases has recently published a study on China’s cardiovascular health. According to the study, 1 in 5 Chinese are in “poor cardiovascular shape,” while 1 person dies from a heart disease every 10 seconds.
Doctors and physicians are predicting an increase in heart disease-related issues over the next decade. These predictions are based on statistics revealing that coronary heart disease cases among Chinese citizens between 35 and 44 has increased by 30% in the past three years. The death rate from such cases has increased by over 100% in the last 15 years. Accordingly, professionals are recommending that China implement a national intervention program to improve China’s cardiovascular health.
In response to the rise of cardiovascular disease cases, the demand for treatment products in China is rapidly growing. While more and more domestic Chinese companies are manufacturing increasingly sophisticated cardiology products to keep up with the demand, high-end products are still likely to be imported from the U.S. or Europe, creating many opportunities for Western medical companies.